Results 191 to 200 of about 1,871,652 (269)

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Correction: Cell-free mitochondrial DNA as a potential predictor for hypoxic stress. [PDF]

open access: yesMol Biol Rep
Qu Q   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy